Radiotherapy for elder patients aged ≥80 with clinically localized prostate cancer – Brachytherapy enhanced late GU toxicity especially in elderly

MLA

Haruumi Okabe, et al. “Radiotherapy for Elder Patients Aged ≥80 with Clinically Localized Prostate Cancer – Brachytherapy Enhanced Late GU Toxicity Especially in Elderly.” Clinical and Translational Radiation Oncology, vol. 25, Nov. 2020, pp. 67–74. EBSCOhost, https://doi.org/10.1016/j.ctro.2020.09.008.

APA

Haruumi Okabe, Koji Okihara, Takumi Shiraishi, Norihiro Aibe, Atsuko Fujihara, Ken Yoshida, Hideya Yamazaki, Koji Masui, Gen Suzuki, Satoaki Nakamura, Osamu Ukimura, Kei Yamada, & Daisuke Shimizu. (2020). Radiotherapy for elder patients aged ≥80 with clinically localized prostate cancer – Brachytherapy enhanced late GU toxicity especially in elderly. Clinical and Translational Radiation Oncology, 25, 67–74. https://doi.org/10.1016/j.ctro.2020.09.008

Chicago

Haruumi Okabe, Koji Okihara, Takumi Shiraishi, Norihiro Aibe, Atsuko Fujihara, Ken Yoshida, Hideya Yamazaki, et al. 2020. “Radiotherapy for Elder Patients Aged ≥80 with Clinically Localized Prostate Cancer – Brachytherapy Enhanced Late GU Toxicity Especially in Elderly.” Clinical and Translational Radiation Oncology 25 (November): 67–74. doi:10.1016/j.ctro.2020.09.008.